Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
Rising Risk? Here's What You Can Buy
03:21pm, Friday, 24'th Jul 2020
Volatility caused by dismal economic data creates opportunities. Our overbought reading is heating up, suggesting you proactively pick entry points.
QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher
12:00am, Wednesday, 22'nd Jul 2020
QIAGEN announces publication of Supplemental Reasoned Position Statement for proposed acquisition by Thermo Fisher
Kronos Bio Appoints Barbara Kosacz, Chief Operating Officer and General Counsel
12:00am, Monday, 20'th Jul 2020
Kronos Bio, Inc., a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to trans
Why Becton, Dickinson & Co (BDX) is an Attractive Pick for Investors
05:00pm, Friday, 17'th Jul 2020
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Equity Income Fund posted a return of 18.29% for the quarter, underperforming its benchmark, th
2 Top Pharma Stocks to Buy in a Recession
11:34am, Friday, 17'th Jul 2020
When the economy struggles, these two pharma companies take it in stride because they know the rest of the industry depends on them for critical products.
Emerging Market and Legal Trends in the Top Five Global Startup Ecosystems
11:15am, Friday, 17'th Jul 2020
The recently published Global Startup Ecosystem Report 2020 ranks the top global startup ecosystems by metrics including performance, funding, connectedness, talent, and knowledge to highlight the win
T Rowe Price Equity Income Fund's Top 5 Buys in the 2nd Quarter
11:30pm, Thursday, 16'th Jul 2020
Fund of Baltimore-based firm establishes new holdings in Merck and Volkswagen Continue reading...
Colliers International Group Inc. Announces Normal Course Issuer Bid
11:30am, Thursday, 16'th Jul 2020
TORONTO, July 16, 2020 -- Colliers International Group Inc. (NASDAQ: CIGI) (TSX: CIGI) (“Colliers”) announced today that the Toronto Stock Exchange (the “TSX”) has accepted a.
U.S. government agrees to buy Becton's COVID-19 testing devices
03:26am, Thursday, 16'th Jul 2020
The U.S. Department of Health and Human Services has agreed to buy 2,000 of its BD Veritor Plus Systems and 750,000 of its SARS-CoV-2 antigen test kits, the company said. According to U.S. health exp
Becton Dickinson Covid Test Systems Bought by U.S. Government
04:16pm, Wednesday, 15'th Jul 2020
Becton Dickinson's system will 'significantly expand testing ... for the benefit of all Americans,' the government said.
Becton, Dickinson Score Fed Contract For Covid-19 Rapid Test Systems
12:46pm, Wednesday, 15'th Jul 2020
Becton, Dickinson and Co (BDX) has announced that the U.S. Department of Health and Human Services (HHS) will purchase 2,000 of its BD Veritor Plus Systems and 750,000 SARS-CoV-2 antigen test kits for
U.S. government agrees to buy Becton's COVID-19 testing device
11:47am, Wednesday, 15'th Jul 2020
Becton, Dickinson and Co said on Wednesday the U.S. government had agreed to buy its COVID-19 testing device and kits. The U.S. Department of Health and Human Services has agreed to buy its 2,000 BD
BD to sell 750,000 coronavirus tests to U.S. government
11:22am, Wednesday, 15'th Jul 2020
Becton Dickinson and Co. said Wednesday that the U.S. government plans to buy 750,000 of the company's COVID-19 antigen diagnostic tests. The purchase will also include 2,000 systems manufactured by
BD Supports U.S. Government Efforts to Increase COVID-19 Testing Capacity with Point-of-Care Tests
10:59am, Wednesday, 15'th Jul 2020
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today a commitment from the U.S. Department of Health and Human Services (HHS) to purchase BD dia
Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?
04:10pm, Tuesday, 14'th Jul 2020
Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
